
Proactive and disciplined pre-med student at the University of New Mexico, majoring in Biochemistry with a minor in Health Medicine and Human Values. Offers two years of hands-on cancer research experience, demonstrating proficiency in sterile techniques, mouse procedures, and confocal microscopy, along with a solid background in project planning and presenting findings. Excels in collaborative team environments and public-facing roles while maintaining professionalism and humility. Driven to advance health equity and improve health outcomes for undeserved (Immigrant/Refugee and Native American) communities across New Mexico. Committed to starting medical school in Fall 2028 and with plans to pursue a residency in medical oncology with the intention of providing holistic, culturally competent, and accessible healthcare in New Mexico and Venezuela.
Undergraduate Research Opportunity Conference (04/17/2026)
University of New Mexico, Albuquerque New Mexico
Toll-Like Receptor Agonist Vaccine Mediated Enrichment of Omental Immune Niches in Ovarian Cancer
American Association for Cancer Research Ovarian Cancer Conference (09/19 - 21/2025)
Grand Hayatt, Denver Colorado
Tissue Clearing and Light-Sheet Microscopy: Spatial Dynamics of Omental Milky Spots
Undergraduate Pipeline Network Summer Research Symposium (08/04/2023)
University of New Mexico, Albuquerque New Mexico
Microbial Mimetic Platforms for Cancer Immunotherapy (Cell vs Microparticles)
Chakraborty T., Serda R., Kennedy E., & Sain N., BPS2026-Dynamic waist control for signal enhancement and multi-scale axial resolution in axially swept light-sheet microscopy. Biophysical Journal, 2026;4(1):125218a. doi: 10.1016/j.bpj.2025.11.1455
Marweed B, De May H, Kennedy E., et al. TLR Agonist Nano Immune Therapy Clears Peritoneal and Systemic Ovarian Cancer. Adv Health Mater. 2025;14(7):2402966. doi:10.1002/adhm.202402966
Marweed B, Medina LY, Kennedy E., et al. Regional immune mechanisms enhance efficacy of an autologous cellular cancer vaccine with intraperitoneal administration. Oncoimmunology. 2024;13(1):2421029. doi:10.1080/2162402X.2024.2421029